Verastem (VSTM) Liabilities and Shareholders Equity (2011 - 2026)

Verastem's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $227.8 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 72.98% year-over-year to $227.8 million; the TTM figure through Mar 2026 stood at $847.4 million (up 82.09% YoY), while the FY2025 annual figure was $246.4 million, up 142.71% from the prior year.
• Liabilities and Shareholders Equity was $227.8 million for Q1 2026 at Verastem, down from $246.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $246.4 million in Q4 2025 to a low of $95.0 million in Q4 2022.
• Historically, Liabilities and Shareholders Equity has averaged $146.9 million across 5 years, with a median of $126.4 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity sank 44.85% in 2024, then soared 142.71% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $95.0 million in 2022, then soared by 57.51% to $149.7 million in 2023, then slumped by 32.18% to $101.5 million in 2024, then jumped by 142.71% to $246.4 million in 2025, then fell by 7.56% to $227.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $227.8 million (Q1 2026), $246.4 million (Q4 2025), and $176.9 million (Q3 2025), per Business Quant data.